Additionally, Adjusted EPS excludes the impact of special items and amortization expense associated with intangible assets. 2 O P E N I N G RE MARK S B O B P A T T E R S O N C H A I R M A N , P R E S I D E N T A N D C E O Complementary technologies and customer relationships offer opportunity to advance commercial strategy Dyneema®, the world’s strongest fiber™, to accelerate growth of sustainable, ultralight and high performance applications AVIENT PROTECTIVE MATERIALS FIRST YEAR 4 Composites comprises over half of Specialty Engineered Materials, compared to 9% in 2016 Proven history of success in areas such as outdoor high performance, defense and sustainable solutions Composites 44% 56% 2023E Sales Collaboration & InnovationComposites as a % of SEM People & Culture Talented, passionate, and creative associates drive continued integration success and allow two cultures to come together as one Avient Lightweight Protective Laminates: PROJECTILE PROTECTION Dyneema® Fiber Solutions Cushioning + Fit + Comfort: LONG-TERM WEAR reSound™ Versaflex™ Thermoplastic Elastomers Strength + Durability + Light-Weighting: SOLID MOUNTING BRACKETS Nymax™ Bergamid™ Complēt™ Engineered Materials Durability + Lubricity: HELMET LATCHES Lubri-One™ Internally Lubricated Polymers Color Consistency and Weatherability CUSTOMIZED SPECIFICATIONS Avient Color and Additive Solutions Antennae Performance FAST, RELIABLE CONNECTIONS PREPERM™ Low-Loss Dielectric Thermoplastics AVIENT PROTECTIVE MATERIALS CROSS SELLING OPPORTUNITIES Wired Connections CONSTANT COMMUNICATION Syncure™ Cross-linkable Wire & Cable Formulations5 6 AVIENT PROTECTIVE MATERIALS CROSS SELLING OPPORTUNITIES 6 Q 3 P E RFO RMAN CE 15.4% 16.3% 2022 PF 2023 Results vs. GUIDANCE $800 $754 $128 $123 Sales Adjusted EBITDA $0.56 $0.57 Adjusted EPS 9 • Demand impacted by destocking and cautious customer sentiment • Positive net price benefit: o CAI - Pricing flat and raw material deflation o SEM - Pricing flat with unfavorable mix related to healthcare, more than offset with raw material deflation • Cost reductions driven by Clariant synergies and reduced administrative costs Q3 EBITDA BRIDGE ($ millions) CAI: Price / Mix -) Deflation 22) SEM: Price / Mix (6) Deflation 13) Net Price Benefit 29) Cost Reductions 13) Wage Inflation (8) FX 1) Q3 2023 Actual $ 123) Adjusted EBITDA Q3 2022 Pro Forma $ 137) Demand (49) 10 2023 G U I DAN CE Q4 2023 GUIDANCE VS. PRIOR YEAR $790 $710 2022 2023 $107 $112 2022 2023 Sales Adjusted EBITDA $0.42 $0.47 2022 PF 2023 Adjusted EPS - 10% + 5% + 12% Sales Adjusted EBITDA Adjusted EPS 12 $112 $500 $0.47 $2.30 Q4 AND FULL YEAR 2023 GUIDANCE $710 $3,130 Sales Adjusted EBITDA Adjusted EPS 13 (in millions) (in millions) Guidance: Free Cash Flow $180 $180 Prior Guidance Guidance FREE CASH FLOW & INCREASED DIVIDEND 13th Consecutive Dividend Increase 0.16 0.26 0.42 0.58 0.79 0.85 0.99 1.03 2011 2013 2015 2017 2019 2021 2023 2024 14 S U S TAI NABI L I T Y DAY RE CAP SUSTAINABILITY AS A GROWTH DRIVERLONG-TERM REVENUE GROWTH DRIVERS 60%+ Key Growth Drivers Sustainable Solutions Composites, Healthcare, Asia / LATAM Overlap Other (GDP Growth) Total Company Revenue Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Composites 8–10% Healthcare 8–10% Asia / LATAM 5% Other (GDP growth) 0–2% Avient 6% 17 SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH 8-12% Long Term Growth 50 90 2022 2030 Medical Plastics Market Size (in $Billions) 2020 2030 Recycled Plastics Virgin Plastics Growing Demand for Recycled Content Avient Sustainable Solutions 18 46 2023 2032 Global Offshore Annual Wind Installations (in Gigawatts) Sources: McKinsey, Bloomberg, Grand View Research SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH 18 • Transformative acquisitions combined with divestitures of more cyclical businesses have improved margins over 400 bps since 2018 • 20% long-term margin goal to be driven by key growth drivers, with sustainable solutions playing a meaningful role 5.4% 11.5% 16.0% 2006 2018 2023E Recovery Growth Drivers Strategic Objective 20%+ +1%+ +3%+ ADJUSTED EBITDA MARGIN EXPANSION 19 • 6% annualized long-term sales growth leveraging sustainable solutions, composites, healthcare, and emerging regions • Expand EBITDA margins to 20% • Deliver annual EBITDA and EPS growth of 10% and 15% • Maintain asset-light, 80% free cash flow conversion profile and be valued as a specialty formulator • Continue fostering our Great Place to Work® culture CREATING A WORLD-CLASS SUSTAINABLE ORGANIZATION 20 Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

ACTIVE INGREDIENTS RESISTANCE RATING Clorox® Disinfecting Wipes 5813-79 Quaternary ammonium +++++ +++++ +++++ ++ +++ ++++ Formula 409® Heavy Duty Degreaser N/A Lauramine oxide, ethanolamine +++++ +++++ +++++ + ++ +++ Lysol® All-Purpose Cleaner 777-66 Quaternary ammonium +++++ +++++ +++++ + + ++ $$$ $$$ $$$$ $ $$$ $ MATERIAL COMPARISON WITH COMMON CONSUMER DISINFECTANTS P AB S P PE T P PB T E 90 0 CR E 90 0 H I C R E 92 0 C RCRITERIA FOR RESISTANCE RATING + strength and elongation at yield retention between 90-110% + strength and elongation at yield retention between 75-125% + no statistically significant reduction in elongation at break (p < 0.05) + visual observation score of 4 or better (minor/no crazing, no cracks) + samples survived disinfectant exposure in strain jig Lysol® is a trademark of Reckitt Benckiser LLC Formula 409® is a trademark of The Clorox Company Clorox® is a trademark of The Clorox Company An independent, A2LA-accredited lab tested the following polymers with various disinfectants to help customers choose the material suitable for their specific application requirements.

GLS™ TPE INFANT CARE SOLUTIONS REGULATORY COMPLIANT MATERIALS FOR YOUR BABY CARE PRODUCTS GRADE PRODUCT HARDNESS REGULATORY COMPLIANCE* – FDA, EU, GB CL2242 Pacifiers Teething 43 Shore A FDA 177.1210 — — Versaflex™ CL2250 Pacifiers Teething 50 Shore A FDA 177.1210 — — Versaflex™ FFC 2882-87 87 Shore A FDA 177.2600 EU 10/2011 GB 9685-2008 FFC 2882-50 50 Shore A FDA 177.2600 EU 10/2011 — G2701C 66 Shore A FDA 177.2600 — — Dynaflex™ G6770 69 Shore A FDA 177.2600 EU 10/2011 GB 9685-2008 Dynaflex™ G2780C 84 Shore A FDA 177.2600 — — Dynaflex™ G7600 series 30A-80 Shore A FDA 177.1210 — — Dynalloy™ GP 7810 & 7820 Bathtubs Bibs Placemats 30A-70 Shore A General FDA — — We believe that the smallest consumers deserve the very best.

GUIDANCE 8 15.4% 15.9% Adjusted EBITDA Margin % Better-than-expected margins driven by: • Favorable mix - strong demand for composite applications • Raw material deflation Q2 EBITDA BRIDGE 9 ($ millions) CAI: Price / Mix 7) Deflation 11) SEM: Price / Mix 2) Deflation 6) Net Price Benefit 26) Wage and Energy Inflation (10) Cost Reductions 13) FX (2) Q2 2023 Actual $131) Adjusted EBITDA Q2 2022 Pro Forma $ 172) Demand (68) • Demand conditions vs. expectations: LATAM • Net price benefit remains greater than wage and energy inflation • Clariant synergies and reduced administrative costs Q2 2023 SEQUENTIAL SALES BY REGION Q 2 2 0 2 3 v s . Q 1 2 0 2 3 -8% +6% -1% Flat 10 Total Avient -2.6% 2023 G U IDA N CE $128 $525 $0.56 $2.40 2023 GUIDANCE 12 $800 $3,280 Sales Adjusted EBITDA Adjusted EPS (in millions) (in millions) 13 • Focused on working capital management, restructuring actions to streamline operations • IT investment to further integrate acquired businesses and capture operational efficiencies • Preserve Free Cash Flow to maintain net leverage CASH FLOW / LEVERAGE ($ millions) 2023E Cash Flow from Operating Activities 320$ Less: CapEx (140) Free Cash Flow 180$ Adjusted EBITDA 525$ Net Debt / Adjusted EBITDA 3.0x SUSTAINABILITY AS A GROWTH DRIVER 14 LONG-TERM REVENUE GROWTH DRIVERS Revenue From Sustainable Solutions* 2016-2022 $340M $405M $455M $550M $790M $915M 2016 2017 2018 2019 2020PF** 2021 2022PF*** $1,175M *Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Green Guides”) **2020 is Pro Forma to include full year of the Clariant Color business ***2022 is Pro Forma for the acquisition of Avient Protective Materials and the divestiture of Distribution 60%+ Key Growth Drivers Sustainable Solutions Composites, Healthcare, Asia / LATAM Overlap Other (GDP Growth) Total Company Revenue SUSTAINABILITY REPORT 2022 • Provides progress on 2030 goals • Reaffirms commitment to U.N. Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years. 24 EV / 2023E EBITDA Historic Multiple 6.5 8.3 10.3 14.4 13.6 13.6 12.4 9.0 20.2 18.2 11.5 10.6 9.7 9.6 8.7 8.3 01 1) 01 8) 02 3) Avient Specialty Other Specialty / SEGMENT DATA U.S. & Canada 40% 37% 18% 2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS 20% 24% Building and END MARKET REVENUE $2,355M $402M $1,300M $272M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $592M$3,653M (1) 9% 26 (1) Total company sales and adjusted EBITDA of $3,653M and $592M, respectively, include intercompany sales eliminations and corporate costs 2022 REVENUE | $2 .4 B ILL ION 34% 38% 20% END MARKET REGION 27 34% 21% Building & 1% Energy 2% COLOR, ADDITIVES & INKS 2022 PRO FORMA REVENUE | $1 .3 B ILL ION 52% 35% 28 19% 8%Industrial 16% 9% Defense Building & END MARKET REGION SPECIALTY ENGINEERED MATERIALS 32% 27% 14% Building & 3% 1% Defense 1% (18% of sales) 9% 2022 PROFORMA AVIENT REGIONAL SALES 27% 14% 17% Building & (37% of sales)Transportation 24% 12% Building & US & Canada (40% of sales) 7% 56% 23% 7% Building & 1% LATAM (5% of sales) 3% 29 BY END MARKET Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF AMENDMENT OF “CLARIANT PLASTICS & COATINGS USA LLC”, CHANGING ITS NAME FROM "CLARIANT PLASTICS & COATINGS USA LLC" TO "AVIENT COLORANTS USA LLC", FILED IN THIS OFFICE ON THE ELEVENTH DAY OF JANUARY, A.D. 2021, AT 10:39 O`CLOCK A.M.

G1QCertificate Number: 82756 Certificate of Incorporation on Change Of Name For Registrar of Companies I hereby certify that CLARIANT PLASTICS & COATINGS (IRELAND) LIMITED having, by a Special Resolution of the Company, and with the approval of the Registrar of Companies, changed its name, is now incorporated as a LTD - Private Company Limited by Shares under the name AVIENT COLORANTS IRELAND LIMITED and I have entered such name on the Register accordingly.

F548 White Foam / Clariant WHITE PP FR 8-6 LMS-1000

PolyOne Completes Clariant Masterbatch Acquisition, Announces New Name: Avient Corporation...

PolyOne Completes Clariant Masterbatch Acquisition, Announces New Name: Avient Corporation

CLEVELAND, March 16, 2020 /PRNewswire/ -- In anticipation of closing the acquisition of Clariant Masterbatch later this year, PolyOne Corporati